文献速递重症综合管理与镇静镇痛

危重症后睡眠轨迹:24个月随访研究

The trajectory of sleep after critical illness: a 24-month follow-up study.
PubMed 文献 · Ann Intensive Care · 2025-02-28
一句话结论危重症幸存者中,部分患者需长达24个月才能完全恢复睡眠质量,相当比例患者在此期内无临床显著改善,睡眠轨迹与心理健康状态密切相关。

本研究为观察性前瞻性研究,纳入ICU期间确诊SARS-CoV-2感染的196例患者(69.9%男性,中位年龄62.0 [53.0;67.2]岁),在出院后短期、12个月和24个月评估睡眠(PSQI)、心理健康(HADS)、生活质量(SF-12)。全球人群PSQI评分从短期评估至24个月随访的平均变化为-0.91(95%CI -1.50至-0.31)分。基于PSQI轨迹识别出三组:健康组(短期睡眠质量好并维持)、MCII组(短期睡眠差但随时间改善至与健康组相当)、非MCII组(整个随访期持续睡眠差)。PSQI轨迹与HADS及SF-12精神评分轨迹密切一致。

要点

  • 危重症幸存者PSQI评分从短期至24个月平均变化-0.91(95%CI -1.50至-0.31)分,整体睡眠有改善但幅度有限。
  • 基于PSQI轨迹分为三组:健康组、MCII组(短期差后改善至与健康组相当)、非MCII组(持续差)。
  • 相当比例患者(非MCII组)在24个月内未达到睡眠质量的临床显著改善(PSQI下降≥4分)。
  • PSQI轨迹与HADS及SF-12精神评分轨迹密切一致,提示睡眠与心理健康同步变化。
  • 作者认为应将睡眠与心理健康共同纳入PICS(重症后综合征)管理框架。

适用人群与场景

  • ICU期间确诊SARS-CoV-2感染的危重症幸存者,出院后随访至24个月。
  • 队列196例,69.9%男性,中位年龄62.0 [53.0;67.2]岁。

诊断标准与关键阈值

  • 睡眠质量好定义为PSQI评分≤5分。
  • 最小临床重要改善(MCII)定义为短期评估至24个月随访PSQI评分下降≥4分。

研究设计与关键结果

  • 观察性前瞻性研究,纳入196例ICU期间确诊SARS-CoV-2感染患者,出院后短期、12个月和24个月评估PSQI、HADS、SF-12。
  • 全球人群PSQI评分从短期至24个月平均变化-0.91(95%CI -1.50至-0.31)分。
  • 基于PSQI轨迹识别三组:健康组(短期睡眠好并维持)、MCII组(短期睡眠差但改善至与健康组相当)、非MCII组(持续睡眠差)。
  • PSQI轨迹与HADS及SF-12精神评分轨迹密切一致。

证据类型、等级与局限

  • 证据类型:观察性前瞻性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,应在重症后综合征框架内将睡眠与心理健康共同管理。
  • 作者指出,部分危重症幸存者需长达24个月才完全恢复睡眠质量,相当比例在此期内无临床显著改善。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Survivors of critical illness endure long-lasting physical and mental challenges. Despite the persistence of poor sleep quality in a considerable proportion of patients at the 12-month follow-up, studies with assessments exceeding this period are limited. We aimed to investigate the trajectory of sleep over the 24 months following critical illness.

METHODS: Observational, prospective study. Patients diagnosed with SARS-CoV-2 infection were recruited during the intensive care unit stay. Evaluations of sleep (Pittsburgh Sleep Quality Index [PSQI]), mental health (Hospital Anxiety and Depression Scale [HADS]), quality of life (12-item Short Form Survey [SF-12]), and other factors were performed in the short-term, and at 12 and 24 months after hospital discharge. Good sleep quality was defined as a PSQI score of ≤ 5. Minimal clinically important improvement (MCII) was defined as a decrease of ≥ 4 points in the PSQI score between the short-term assessment and the 24-month follow-up.

RESULTS: The cohort included 196 patients (69.9% males), with a median [p25;p75] age of 62.0 [53.0;67.2] years. The global population showed a mean (95% CI) change of - 0.91 ( - 1.50 to - 0.31) points in the PSQI score from the short-term assessment to the 24-month follow-up. Based on PSQI score trajectories, three distinct groups of patients were identified: (i) the healthy group, consisting of patients with good sleep quality in the short-term that was maintained throughout the follow-up period; (ii) the MCII group, consisting of patients with poor sleep quality in the short-term, but with improvement over time, ultimately reaching levels comparable to the healthy group; (iii) the non-MCII group, consisting of those with consistently poor sleep quality across the entire follow-up. Further analyses revealed that PSQI score trajectories were closely aligned with those of the HADS and SF-12 mental scores.

CONCLUSIONS: Our findings reveal that a subset of critical illness survivors requires up to 24 months after the acute phase to fully restore their sleep quality, while a significant proportion does not experience a clinically significant improvement in sleep quality over this period. These distinct sleep trajectories are strongly correlated with mental health status, highlighting the importance of addressing sleep alongside mental health within the framework of post-intensive care syndrome.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Henríquez-Beltrán M, Benítez ID, Vaca R, et al. The trajectory of sleep after critical illness: a 24-month follow-up study. Ann Intensive Care. 2025. PMID: 40019644. doi:10.1186/s13613-025-01449-9

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。